Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
The other new treatment involves a vaccine using mRNA technology in patients with pancreatic cancer who had their tumors removed, but were at high risk of the cancer coming back.
- Simplified Text
-
A new treatment for high-risk pancreatic cancer patients with removed tumors involves a vaccine using mRNA technology.
- Confidence Score
- 0.950
- Claim Maker
- The author
- Context Type
- News Article
- Context Details
-
{ "patient_group": "pancreatic cancer patients with removed tumors at high risk of recurrence", "treatment_type": "mRNA vaccine" } - UUID
- f1ce652c-dde3-488e-846a-78ccc96b79a5
- Vector Index
- ā No vector
- Created
- September 18, 2026 at 2:04 AM (3 weeks ago)
- Last Updated
- September 18, 2026 at 2:04 AM (3 weeks ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
30
claims
š„
3 weeks ago
https://nytimes.com/2026/09/17/well/pancreatic-cancer-family-genetic-risk.html
A journalist recounts losing three brothers to pancreatic cancer and his journey to get tested and monitored for the disease. He shares insights into the challenges of early detection and new treatment advancements.
Similar Claims (5)
Other claims identified as semantically similar to this one.
-
Simplified: The drug daraxonrasib, recently approved by the FDA, doubled life expectancy to over 13 months for certain metastatic pancreatic cancer patients in a...3 weeks ago
-
Simplified: In the U.S., pancreatic cancer is the third-leading cause of cancer-related deaths, following lung and colorectal cancers.3 weeks ago
-
Simplified: Moderna is a pioneer in using mRNA technology with the Covid vaccine7 months ago
-
Simplified: A preliminary 2026 study reported that seven of eight patients who responded to a pancreatic cancer vaccine were still alive four to six years after s...1 week ago
-
Dr. Anna Berkenblit, chief scientific and medical officer of the Pancreatic Cancer Action Network. 1.000Simplified: Dr. Anna Berkenblit is the chief scientific and medical officer of the Pancreatic Cancer Action Network.3 weeks ago